Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2022.12.05

Sai Life Sciences releases its Sustainability Report 2022

Sai Life Sciences releases its Sustainability Report 2022

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced the release of its Sustainability Report 2022, which has been developed as per the Global Reporting Initiative (GRI) standards. With the theme ‘Organising for Sustainability Success’ the Report describes the company’s efforts in progressively reducing the knowing-doing gap by proactively addressing sustainability-related material issues. Read the full report here.

Making the announcement, Krishna Kanumuri, CEO & Managing Director said, “Amid a backdrop of climate change and a recognition of urgency in implementing development goals, Sai Life Sciences continues to transform promises into action in its pursuit of sustainability. Our 2022 Sustainability Report, reflects sustained efforts across economic, environment and social cornerstones, and reiterates our ethos – Make it Better Together.”

The third report released by Sai Life Sciences reveals significant progress in multiple areas. Here are a few of the highlights:

  • Retained Silver Medal in the EcoVadis Business Sustainability assessment with an improvement in score from 57 to 63
  • Received LEED Gold certification for the Research & Technology (R&T) Centre in Hyderabad
  • Achieved increased utilization of renewable energy in manufacturing operations from 53% to 67%
  • Received Energy Management System - ISO 50001:2018 certification for Bidar Manufacturing unit
  • Awarded the CII Excellent Energy Efficient Unit for the third consecutive year at our Bidar API manufacturing unit
  • Qualified for the United Nations Global Compact (UNGC) Active Level based on the Communication on Progress (COP)

As part of its organizational transformative initiative, Sai Nxt, the company made significant progress in advancing its Sustainability agenda:

  • Became the first India-headquartered company to join the PSCI membership.
  • Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) as an ‘Associate Member’.
  • Received ISO 14001:2015 and ISO 45001:2018 certifications.
  • Became a signatory of the United Nations Global Compact (UNGC).

The Sustainable Development Goals (SDGs) of the company had been set in 2019 with a three-year timeframe concluding in 2022. Incorporating the learnings from this period, the company is now in the process of envisioning goals and targets for the next phase of its journey.

Share article

More News

2025.10.31

Sai Life Sciences becomes a signatory to the UN Women’s Empowerment Principles

Sai Life Sciences has joined the global community of signatories to the Women’s Empowerment Principles (WEPs) — an initiative established by UN Women and the UN Global Compact (UNGC). The WEPs serve as a global framework for businesses to advance gender equality and empower women in the workplace, marketplace, and community. By becoming a WEPs […]
Read more

2025.10.27

Sai Life Sciences set to double Process R&D capacity with new facility in Hyderabad

Hyderabad, India, October 27, 2025: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the groundbreaking for a new CMC Process R&D Center at its integrated R&D campus in Hyderabad. Scheduled for completion by September 2026, the facility will double the […]
Read more

2025.10.08

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators

Manchester/Hyderabad, October 08, 2025: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC Partnership designed to provide innovator biopharma companies with end-to-end Chemistry, Manufacturing and Controls (CMC) services. The collaboration combines the extensive CMC expertise of Sai Life Sciences in API […]
Read more

2025.10.06

Unlocking Chemical Frontiers: IIT Bombay Prof, Debabrata Maiti at Sai Life Sciences

As part of Sai Life Sciences’ efforts to foster knowledge exchange and bring leading voices from niche areas of science and technology to its teams, the company recently hosted Prof. Debabrata Maiti from the Indian Institute of Technology (IIT) Bombay at its R&D campus in Hyderabad for a day of scientific exchange and dialogue. The […]
Read more

2025.09.18

Sai Life Sciences opens dedicated facility for Veterinary APIs in Bidar, India

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for veterinary API production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. The new […]
Read more